S Chatfield

4.2k total citations
57 papers, 3.4k citations indexed

About

S Chatfield is a scholar working on Food Science, Infectious Diseases and Endocrinology. According to data from OpenAlex, S Chatfield has authored 57 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Food Science, 27 papers in Infectious Diseases and 19 papers in Endocrinology. Recurrent topics in S Chatfield's work include Salmonella and Campylobacter epidemiology (35 papers), Viral gastroenteritis research and epidemiology (24 papers) and Bacteriophages and microbial interactions (18 papers). S Chatfield is often cited by papers focused on Salmonella and Campylobacter epidemiology (35 papers), Viral gastroenteritis research and epidemiology (24 papers) and Bacteriophages and microbial interactions (18 papers). S Chatfield collaborates with scholars based in United Kingdom, United States and Australia. S Chatfield's co-authors include Gordon Dougan, Mark Roberts, Derek Pickard, Neil F. Fairweather, Ian G. Charles, Charles J. Dorman, C. Hayward, J P Tite, Richard A. Strugnell and Jerry R. McGhee and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Nature Biotechnology.

In The Last Decade

S Chatfield

56 papers receiving 3.3k citations

Peers

Countries citing papers authored by S Chatfield

Since Specialization

Citations

This map shows the geographic impact of S Chatfield's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S Chatfield with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S Chatfield more than expected).

Fields of papers citing papers by S Chatfield

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S Chatfield. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S Chatfield. The network helps show where S Chatfield may publish in the future.

Co-authorship network of co-authors of S Chatfield

This figure shows the co-authorship network connecting the top 25 collaborators of S Chatfield. A scholar is included among the top collaborators of S Chatfield based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S Chatfield. S Chatfield is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Evaluation of Salmonella enterica serovar Typhi (Ty2 aroC-ssaV-) M01ZH09, with a defined mutation in the Salmonella pathogenicity island 2, as a live, oral typhoid vaccine in human volunteers 2005 ·Vaccine ·Beth D. Kirkpatrick, Robin McKenzie, John P. O’Neill, Catherine J. Larsson, A. Louis Bourgeois, Janet Shimko, Matthew G. Bentley, J. Makin, S Chatfield, Zoë Hindle, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), David N. Taylor	75
2	Characterization of the T‐ and B‐cell immune response to a new recombinant pre‐S1, pre‐S2 and SHBs antigen containing hepatitis B vaccine (Hepagene™); evidence for superior anti‐SHBs antibody induction in responder mice 1998 ·Journal of Viral Hepatitis ·Chris Jones, Mark Page, Andrew Bacon, (unknown), Matthew G. Bentley, S Chatfield	14
3	Immune responses in calves immunised orally or subcutaneously with a live Salmonella typhimurium aro vaccine 1998 ·Vaccine ·Bernardo Villarreal‐Ramos, (unknown), Robert A. Collins, Gordon Dougan, S Chatfield, Christopher J. Howard	40
4	The development of oral vaccines against parasitic diseases utilizing live attenuatedSalmonella 1995 ·Parasitology ·S Chatfield, Mark Roberts, Gordon Dougan, Carlos E. Hormaeche, C. M. Anjam Khan	27
5	Mucosal and systemic immunogenicity of a recombinant, non-ADP-ribosylating pertussis toxin: effects of formaldehyde treatment 1995 ·Vaccine ·Ian Cropley, Gill Douce, Mark Roberts, S Chatfield, Mariagrazia Pizza, I. Marsili, Rino Rappuoli, Gordon Dougan	23
6	Construction, expression, and immunogenicity of multiple tandem copies of the Schistosoma mansoni peptide 115-131 of the P28 glutathione S-transferase expressed as C-terminal fusions to tetanus toxin fragment C in a live aro-attenuated vaccine strain of Salmonella . 1994 ·The Journal of Immunology ·C. M. Anjam Khan, Bernardo Villarreal‐Ramos, Raymond J. Pierce, Raquel Demarco de Hormaeche, Hesta McNeill, Tariq Ali, S Chatfield, A Capron, Gordon Dougan, Carlos E. Hormaeche	47
7	The development of oral vaccines based on live attenuatedSalmonellastrains 1993 ·FEMS Immunology & Medical Microbiology ·S Chatfield, Mark Roberts, (unknown), Ian Cropley, Gill Douce, Gordon Dougan	40
8	The development of oral vaccines based on live attenuated Salmonella strains 1993 ·FEMS Immunology & Medical Microbiology ·S Chatfield	0
9	Protection of mice against respiratory Bordetella pertussis infection by intranasal immunization with P.69 and FHA 1993 ·Vaccine ·Mark Roberts, Ian Cropley, S Chatfield, Gordon Dougan	42
10	Construction of a genetically defined Salmonella typhi Ty2 aroA, aroC mutant for the engineering of a candidate oral typhoid-tetanus vaccine 1992 ·Vaccine ·S Chatfield, Neil F. Fairweather, Ian G. Charles, Derek Pickard, Myron M. Levine, David M. Hone, Manuel Posada de la Paz, Richard A. Strugnell, Gordon Dougan	63
11	Impaired resistance to infection does not increase the virulence of Salmonella htrA live vaccines for mice 1992 ·Microbial Pathogenesis ·Karen Strahan, S Chatfield, J P Tite, Gordon Dougan, Carlos E. Hormaeche	20
12	Characterization of a Salmonella choleraesuis mutant that cannot multiply within epithelial cells 1991 ·Canadian Journal of Microbiology ·B. Brett Finlay, S Chatfield, Ka Yin Leung, Gordon Dougan, Stanley Falkow	13
13	Complete nucleotide sequence of the aroA gene fromSalmonella typhiencoding 5-enolpyruvylshikimate 3-phosphate synthase 1990 ·Nucleic Acids Research ·S Chatfield, Gordon Dougan, Ian G. Charles	1
14	Alternative methods of attenuating Salmonella species for potential vaccine use 1990 ·Research in Microbiology ·D.R. Wilson, S Chatfield, (unknown), (unknown), Ka Yin Leung, Gordon Dougan, B. Brett Finlay	1
15	Bacteriophage P22 as a vehicle for transducing cosmid gene banks between smooth strains of Salmonella typhimurium: Use in identifying a role for aroD in attenuating virulent Salmonella strains 1989 ·Molecular and General Genetics MGG ·Irene Miller, S Chatfield, Gordon Dougan, (unknown), Heather S. Joysey, Carlos E. Hormaeche	31
16	Live Salmonella as vaccines and carriers of foreign antigenic determinants 1989 ·Vaccine ·S Chatfield, Richard A. Strugnell, Gordon Dougan	51
17	Characterisation of the cell envelope of Treponema hyodysenteriae 1988 ·FEMS Microbiology Letters ·S Chatfield	2
18	Identification and characterization of TnphoA mutants of Salmonella that are unable to pass through a polarized MDCK epithelial cell monolayer 1988 ·Molecular Microbiology ·B. Brett Finlay, Michael N. Starnbach, (unknown), (unknown), S Chatfield, Gordon Dougan, Stanley Falkow	128
19	Oral vaccination 1988 ·Antonie van Leeuwenhoek ·Gordon Dougan, Duncan J. Maskell, David O’Callaghan, S Chatfield, Ian G. Charles, Carlos E. Hormaeche	3
20	Construction and Characterization of Vaccine Strains of Salmonella Harboring Mutations in Two Different aro Genes 1988 ·The Journal of Infectious Diseases ·Gordon Dougan, S Chatfield, Derek Pickard, (unknown), (unknown), Duncan J. Maskell	70

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact